Back to all events
Datum
25 June 2026 13:00–16:00
Location
Gevers Office, Diegem
Price
€ 0.00
for members
Organized by
Biovia
Event type News labels / tags
Finance
Medical biotech

De-risking biotech in a capital-constrained era [postponed]

De-risking biotech in a capital-constrained era

Important notice: This workshop will not take place as scheduled. We are currently exploring a future edition and will communicate any updates as they become available. If you would like to stay informed or are interested in the topic, please contact rita.prota@biovia.be to express your interest and help shape future programming.

###

Join our interactive workshop on 25 June and learn how medical biotech companies can systematically reduce technical, regulatory, IP and investment risk to become fundable today.

Our hosts and speakers:

  • QbD Group (Regulatory & development strategy): Angeles Escarti-Nebot, Global Head Regulatory Affairs
  • Gevers (IP strategy): Emilie Logie, European and Dutch Patent Attorney & Stijn Lagaert, Partner

By the end of this afternoon of interactive discussions, you'll know what makes a biotech opportunity investable despite uncertainty.

Program

1) Regulatory strategy as de-risking (QbD Group)
“Designing a development path that reduces failure probability”

Topics:

  • Defining the optimal path to market
  • Managing EU/UK/US regulatory divergence
  • Using regulatory pathways as strategic tools
  • Designing trials that satisfy both regulators and payers
  • Avoiding strategic lock-in

2) IP strategy as a lever for de-risking and differentiation (Gevers)
“Making IP decisions that increase investability under capital constraints”

Topics:

  • Making high-impact IP choices with limited capital
  • Freedom-to-operate in crowded spaces
  • Trade secrets vs patents (preserving your options)
  • Managing academic IP and licensing dependencies
  • Aligning filing strategy with value inflection points
  • Patent lifespan vs clinical timelines
  • Using IP intelligence to differentiate from competitors

3) Q&A & Risk
Mapping exercise across regulatory, clinical, IP, financing and manufacturing risks
 

📍 How to get there

Pegasus Park 
De Kleetlaan 7A, 
1831 Diegem

Pegasus Park is about 15 minutes from the city centre of Brussels, five minutes from Brussels Airport and close to all main roads. It is just 45 min to antwerp, 60 min to Ghent and 20 min to Leuven by car. Public transport is within walking distance.

Accessibility by car & public transport: https://www.pegasuspark.be/mobility/ 

This is a free, members-only workshop.

Upcoming events

-
Medical Device Seminar Series 2026 – The EU Medical Device Regulation in Motion: Regulators, Industry and the Road Ahead